Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Epigenomics
Volume 14, 2022 - Issue 9
Research Article
Predictive Significance of Circulating Histones in Hepatocellular Carcinoma Patients Treated with Sorafenib
Francesca Salani1 Sant’Anna School of Advanced Studies, Institute of Life Sciences, Piazza Martiri della Libertà 33, Pisa, 56124, Italy;2 Cancer Research Group-School of Life Health and Chemical Sciences, The Open University, Milton Keynes, MK7 6AA, UK;7 Medical Oncology Department, Pisa University, Via Savi 10, Pisa, 56126, Italy
https://orcid.org/0000-0001-7749-8634View further author information
https://orcid.org/0000-0001-7749-8634View further author information, Maryam Latarani2 Cancer Research Group-School of Life Health and Chemical Sciences, The Open University, Milton Keynes, MK7 6AA, UKhttps://orcid.org/0000-0002-2104-6054View further author information
https://orcid.org/0000-0002-2104-6054View further author information, Andrea Casadei-Gardini3 Department of Oncology, Vita-Salute San Raffaele University, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute Hospital, Milan, Italyhttps://orcid.org/0000-0001-6289-7202View further author information
https://orcid.org/0000-0001-6289-7202View further author information, , Lorenzo Fornaro4 Medical Oncology Department, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56100, Pisahttps://orcid.org/0000-0002-0187-5904View further author information
https://orcid.org/0000-0002-0187-5904View further author information, Caterina Vivaldi5 Department of Translational Research and New Technologies for Medicine and Surgery, University of Pisa, Via Savi 10, Pisa, 56126, Italyhttps://orcid.org/0000-0001-9307-2326View further author information
https://orcid.org/0000-0001-9307-2326View further author information, Irene Pecora6 Unit of Medical Oncology, Ospedale Misericordia di Grosseto,Via Senese, 161, Grosseto, 58100, Italyhttps://orcid.org/0000-0003-2644-2993View further author information
https://orcid.org/0000-0003-2644-2993View further author information, , Giorgia Marisi8 Biosciences Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Romagnolo per lo Studio dei Tumori ‘Dino Amadori,’ Meldola, 47014, Italyhttps://orcid.org/0000-0003-4012-0042View further author information
https://orcid.org/0000-0003-4012-0042View further author information, Matteo Canale8 Biosciences Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Romagnolo per lo Studio dei Tumori ‘Dino Amadori,’ Meldola, 47014, Italyhttps://orcid.org/0000-0002-9768-7149View further author information
https://orcid.org/0000-0002-9768-7149View further author information, Paola Ulivi8 Biosciences Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Romagnolo per lo Studio dei Tumori ‘Dino Amadori,’ Meldola, 47014, Italyhttps://orcid.org/0000-0002-4334-9662View further author information
https://orcid.org/0000-0002-4334-9662View further author information, Mario Scartozzi9 Department of Medical Sciences and Public Health, University of Cagliari, Via Università, 40, CagliariCA, 09124, Italyhttps://orcid.org/0000-0001-5977-5546View further author information
https://orcid.org/0000-0001-5977-5546View further author information, , Gianluca Masi5 Department of Translational Research and New Technologies for Medicine and Surgery, University of Pisa, Via Savi 10, Pisa, 56126, Italyhttps://orcid.org/0000-0001-8329-8989View further author information
https://orcid.org/0000-0001-8329-8989View further author information & Francesco Crea2 Cancer Research Group-School of Life Health and Chemical Sciences, The Open University, Milton Keynes, MK7 6AA, UKCorrespondence[email protected]
https://orcid.org/0000-0002-4903-2973View further author information
https://orcid.org/0000-0002-4903-2973View further author information show all